Cameli P - Search Results

1

A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method.

D'Alessandro M, Bergantini L, Perrone A, Beltrami V, Cameli P, Flori L, Saletti M, Vietri L, Sestini P, Bargagli E. D'Alessandro M, et al. Among authors: cameli p. Minerva Med. 2023 Feb;114(1):94-96. doi: 10.23736/S0026-4806.19.06408-5. Epub 2020 Feb 27. Minerva Med. 2023. PMID: 32108456 No abstract available.

2

Exhaled nitric oxide in interstitial lung diseases.

Cameli P, Bargagli E, Refini RM, Pieroni MG, Bennett D, Rottoli P. Cameli P, et al. Respir Physiol Neurobiol. 2014 Jun 15;197:46-52. doi: 10.1016/j.resp.2014.03.011. Epub 2014 Apr 2. Respir Physiol Neurobiol. 2014. PMID: 24703971

3

Exhaled nitric oxide and carbon monoxide in lung transplanted patients.

Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P. Cameli P, et al. Respir Med. 2015 Sep;109(9):1224-9. doi: 10.1016/j.rmed.2015.07.005. Epub 2015 Jul 9. Respir Med. 2015. PMID: 26224473 Free article.

4

Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.

Cameli P, Bargagli E, Bergantini L, Refini RM, Pieroni M, Sestini P, Rottoli P. Cameli P, et al. J Breath Res. 2019 Mar 27;13(2):026008. doi: 10.1088/1752-7163/ab0233. J Breath Res. 2019. PMID: 30690441

5

Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Bergantini L, Bargagli E, Cameli P, Cekorja B, Lanzarone N, Pianigiani L, Vietri L, Bennett D, Sestini P, Rottoli P. Bergantini L, et al. Among authors: cameli p. Respir Investig. 2019 May;57(3):290-291. doi: 10.1016/j.resinv.2019.02.001. Epub 2019 Feb 21. Respir Investig. 2019. PMID: 30799155 No abstract available.

6

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.

Bergantini L, Bianchi F, Cameli P, Mazzei MA, Fui A, Sestini P, Rottoli P, Bargagli E. Bergantini L, et al. Among authors: cameli p. Dis Markers. 2019 Mar 3;2019:8565423. doi: 10.1155/2019/8565423. eCollection 2019. Dis Markers. 2019. PMID: 30944672 Free PMC article.

7

Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype?

Perruzza M, Fusha E, Cameli P, Capecchi PL, Selvi E, Gentili F, Mazzei MA, Aversa S, Spina D, Di Lucia D, Sestini P, Luzzi L, Bargagli E. Perruzza M, et al. Among authors: cameli p. Respir Med Case Rep. 2019 Apr 17;27:100843. doi: 10.1016/j.rmcr.2019.100843. eCollection 2019. Respir Med Case Rep. 2019. PMID: 31024793 Free PMC article.

8

Serum amyloid A in patients with idiopathic pulmonary fibrosis.

Vietri L, Bennett D, Cameli P, Bergantini L, Cillis G, Sestini P, Bargagli E, Rottoli P. Vietri L, et al. Among authors: cameli p. Respir Investig. 2019 Sep;57(5):430-434. doi: 10.1016/j.resinv.2019.03.010. Epub 2019 Apr 26. Respir Investig. 2019. PMID: 31031123

9

Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.

Cameli P, Bergantini L, Salvini M, Refini RM, Pieroni M, Bargagli E, Sestini P. Cameli P, et al. Nitric Oxide. 2019 Aug 1;89:41-45. doi: 10.1016/j.niox.2019.05.001. Epub 2019 May 2. Nitric Oxide. 2019. PMID: 31054949

10

Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do?

Bargagli E, Mazzei MA, Orlandi M, Gentili F, Bellisai F, Frediani B, Bergantini L, Carobene L, Randone SB, Guiducci S, Cameli P, Bruni C, Cerinic MM. Bargagli E, et al. Among authors: cameli p. Medicine (Baltimore). 2019 Jun;98(26):e16086. doi: 10.1097/MD.0000000000016086. Medicine (Baltimore). 2019. PMID: 31261523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters